Cognitive Functioning in Schizophrenia

[1]  T. Barnes,et al.  Primitive (developmental) reflexes, tardive dyskinesia and intellectual impairment in schizophrenia , 1995, Schizophrenia Research.

[2]  J. Waddington,et al.  Tardive Dyskinesia in Schizophrenia: Relationship to Minor Physical Anomalies, Frontal Lobe Dysfunction and Cerebral Structure on Magnetic Resonance Imaging , 1995, British Journal of Psychiatry.

[3]  R. Buchanan,et al.  The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance , 1994, Biological Psychiatry.

[4]  R. Haier,et al.  Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia , 1994, Schizophrenia Research.

[5]  L. Friedman,et al.  Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine , 1993, Biological Psychiatry.

[6]  B. Sheffield,et al.  Cognitive functions in chronic schizophrenic patients with tardive dyskinesia , 1993 .

[7]  S. Faraone,et al.  Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction , 1993, Biological Psychiatry.

[8]  T. Goldberg,et al.  The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia , 1993, British Journal of Psychiatry.

[9]  Karl J. Friston,et al.  Patterns of Cerebral Blood Flow in Schizophrenia , 1992, British Journal of Psychiatry.

[10]  A. Baddeley,et al.  Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character , 1992, Psychological Medicine.

[11]  Philip D. Harvey,et al.  Continuous performance tests in schizophrenic patients: Stimulus and medication effects on performance , 1991, Psychiatry Research.

[12]  W. Roth,et al.  Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics , 1991, Biological Psychiatry.

[13]  R. McCarley,et al.  Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theory. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[14]  Y. Kakimoto,et al.  Characteristic distribution of alpha 2 wave in electroencephalograms of schizophrenic patients during discriminative tasks: support for the hypofrontality hypothesis of schizophrenia , 1991, Acta psychiatrica Scandinavica.

[15]  D. King.  The Effect of Neuroleptics on Cognitive and Psychomotor Function , 1990, British Journal of Psychiatry.

[16]  A. Baddeley,et al.  Amnesic syndrome in schizophrenia , 1990, Psychological Medicine.

[17]  Philip D. Harvey,et al.  Attentional markers of vulnerability to schizophrenia: Performance of medicated and unmedicated patients and normals , 1990, Psychiatry Research.

[18]  Philip D. Harvey,et al.  Medication may be required for the development of automatic information processing in schizophrenia , 1990, Psychiatry Research.

[19]  R. Tomer.  Neuroleptic effects on interhemispheric and intrahemispheric performance of tactile discrimination tasks by schizophrenic patients , 1990, Psychiatry Research.

[20]  R. Beninger,et al.  Do neuroleptics impair learning in schizophrenic patients? , 1990, Schizophrenia Research.

[21]  Gregory M. Brown,et al.  Neuroleptic drug effects on cognitive function in schizophrenia , 1990, Schizophrenia Research.

[22]  E. Klieser,et al.  Cognitive disturbances in neuroleptic therapy , 1990, Acta psychiatrica Scandinavica. Supplementum.

[23]  J. Harris,et al.  Object-name selection in psychiatric patients before and after neuroleptic therapy , 1990, Journal of psychopharmacology.

[24]  A. Cools,et al.  Haloperidol and cognitive shifting , 1989, Neuropsychologia.

[25]  G. Geffen,et al.  Catecholamines and the covert orientation of attention in humans , 1989, Neuropsychologia.

[26]  M. Strauss,et al.  Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. , 1989, Journal of abnormal psychology.

[27]  D. Healy.  Neuroleptics and Psychic Indifference: A Review , 1989, Journal of the Royal Society of Medicine.

[28]  E. Frecska,et al.  Neurological features, cognitive impairment and neuroleptic response in schizophrenic patients , 1989, Schizophrenia Research.

[29]  P. Flor-Henry,et al.  Neuroleptics reverse attention asymmetries in schizophrenic patients , 1989, Biological Psychiatry.

[30]  G. Laux,et al.  Sensorimotor and Cognitive Performance of Schizophrenic Inpatients Treated with Haloperidol, Flupenthixol, or Clozapine , 1988, Pharmacopsychiatry.

[31]  R. Fields,et al.  Clonidine improves memory function in schizophrenia independently from change in psychosis Preliminary findings , 1988, Schizophrenia Research.

[32]  G. Fein,et al.  Task-related EEG alpha asymmetry in schizophrenic patients prior to and after neuroleptic treatment , 1988, Schizophrenia Research.

[33]  J. Gruzelier,et al.  Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. , 1988, Archives of general psychiatry.

[34]  M. Posner,et al.  Localization of cognitive operations in the human brain. , 1988, Science.

[35]  M. Posner,et al.  How do the parietal lobes direct covert attention? , 1987, Neuropsychologia.

[36]  J. Waddington,et al.  Tardive dyskinesia in schizophrenia and other disorders: Associations with ageing, cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure , 1987 .

[37]  P. Anderer,et al.  Comparative Placebo-controlled Pharmacodynamic Studies with Zotepine and Clozapine Utilizing Pharmaco-EEG and Psychometry , 1987, Pharmacopsychiatry.

[38]  P. Anderer,et al.  Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy , 1986, Pharmacopsychiatry.

[39]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. , 1986, Archives of general psychiatry.

[40]  D. Perlick,et al.  Memory deficits and anticholinergic levels in chronic schizophrenia. , 1986, The American journal of psychiatry.

[41]  L. Coyne,et al.  Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. , 1985, Archives of general psychiatry.

[42]  I. Katz,et al.  Screening for cognitive toxicity of anticholinergic drugs. , 1985, The Journal of clinical psychiatry.

[43]  D. Collerton,et al.  Cognitive performance of medicated schizophrenics with tardive dyskinesia , 1985, Psychological Medicine.

[44]  M. Strauss,et al.  Psychopharmacologic and clinical correlates of attention in chronic schizophrenia. , 1985, The American journal of psychiatry.

[45]  M. Myslobodsky,et al.  Cognitive Impairment in Patients with Tardive Dyskinesia , 1985, The Journal of nervous and mental disease.

[46]  R. Asarnow,et al.  Information processing and neuroleptic response in acute and stabilized schizophrenic patients , 1984, Psychiatry Research.

[47]  W. D. Erickson,et al.  The effects of neuroleptics on attention in adolescent schizophrenics. , 1984, Biological psychiatry.

[48]  R. Gibbons,et al.  Effects of psychotropic medication on selected cognitive and perceptual measures. , 1984, Journal of abnormal psychology.

[49]  V. Reus.  Cognitive changes in schizoaffective patients. , 1983, Archives of general psychiatry.

[50]  E. Walker.  Cognitive Changes in Schizoaffective Patients-Reply , 1983 .

[51]  L. Seidman.  Schizophrenia and brain dysfunction: an integration of recent neurodiagnostic findings , 1983 .

[52]  M. Strauss,et al.  Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. , 1982, The American journal of psychiatry.

[53]  D. Saccuzzo,et al.  Effect of antipsychotic medication on speed of information processing in schizophrenic patients. , 1982, The American journal of psychiatry.

[54]  E. Walker,et al.  Attentional and neuromotor functions of schizophrenics, schizoaffectives, and patients with other affective disorders. , 1981, Archives of general psychiatry.

[55]  A. Meadow,et al.  Cognitive changes in acute schizophrenia with brief neuroleptic treatment. , 1981, The American journal of psychiatry.

[56]  T. Crow,et al.  Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.

[57]  L. Coyne,et al.  Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. , 1977, Archives of general psychiatry.

[58]  D. Hemsley.  A two-stage model of attention in schizophrenia research. , 1975, The British journal of social and clinical psychology.

[59]  H E ROSVOLD,et al.  A continuous performance test of brain damage. , 1956, Journal of consulting psychology.

[60]  S. Galderisi,et al.  Lateralization patterns of event-related potential and performance indices in schizophrenia: relationship to clinical state and neuroleptic treatment. , 1991, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[61]  T. Goldberg,et al.  Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. , 1991, The American journal of psychiatry.

[62]  M. Posner,et al.  The attention system of the human brain. , 1990, Annual review of neuroscience.

[63]  S. Hurt,et al.  The effects of haloperidol on thought disorder and IQ in schizophrenia. , 1990, Journal of personality assessment.

[64]  P. Appelbaum,et al.  Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. , 1990, Schizophrenia bulletin.

[65]  G. Laux,et al.  Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol. , 1989, Neuropsychobiology.

[66]  L. Fogg,et al.  Lateralized cerebral dysfunction in schizophrenia and depression: gender and medication effects. , 1989, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[67]  M Blom,et al.  Effects of single doses of diazepam, chlorpromazine, imipramine and trihexyphenidyl on visual-evoked potentials. , 1988, Neuropsychobiology.

[68]  A. Medalia,et al.  The effects of neuroleptics on neuropsychological test results of schizophrenics. , 1988, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[69]  J. Spray,et al.  Effect of neuroleptic treatments on attention, information processing, and thought disorder. , 1985, Psychopharmacology bulletin.

[70]  R. Oades.  Attention and schizophrenia: Neurobiological bases , 1982 .

[71]  M. Fink.  EEG and human psychopharmacology. , 1969, Annual review of pharmacology.

[72]  C. Kornetsky,et al.  A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients. , 1959, The Journal of mental science.